Pandemics and Alertness member WG2 (Fighting the virus), LINXS Fellow

Professor in Molecular Pharmaceutics at Uppsala University, Sweden. Adjunct Professor in Pharmaceutics at Monash Institute of Pharmaceutical Sciences, Monash University, Australia. Dean Collaboration (Medicine and Pharmacy), Uppsala University. Director of The Swedish Drug Delivery Center. Scientific Platform Director of SciLifLab ADME of Therapeutics. Founder of Kibekon AB, Enphasys AB, Veltio Pharma AB, Extem Pharma AB. CEO of Enphasys AB.

Dr Bergström is Professor in Molecular Pharmaceutics at Uppsala University, Sweden, and adjunct Professor at Monash University, Australia. She is heading a research group of ~30 people focusing on delivery of problematic compounds (poorly solubles, biologics). Her expertise area is within advanced drug delivery systems with focus on biorelevant profiling, computational prediction and novel manufacturing techniques. She is the Center Director of The Swedish Drug Delivery Center – an academic-industry partnership with 18 industrial partners from Sweden, Denmark, Finland, Norway, Belgium and Italy. Dr Bergström has attracted funding to her research program from highly competitive sources, including the24 European Research Council (3), the Swedish Research Council (7), the National Institute of Health and the Swedish Foundation for Strategic Research. She has published >130 papers and book chapters and has been cited >9500 times (h-index of 52). She is a sought for member of grant evaluation panels and scientific advisory boards.

Dr Bergström is a cofounder of the Nordic Pharma Network, an EXCO member of the Nordic University Hub within patient-oriented products (the Nordic POP initiative) and coordinator of the newly established Nordic Pharma Train initiative. She is also an EXCO member of the Globalization Pharmaceutics Education Network. She has founded four companies supporting companies in the drug delivery and development area. In 2017, she was elected Dean of collaboration (Medicine and Pharmacy) at Uppsala University. In this role, she is engaged in outreach activities, identification and establishment of strategic partnerships, interactions with governmental departments of importance for health and education, as well as increasing the academic awareness of the innovation system. In 2018, she became associate editor for the journal Molecular Pharmaceutics.